Oesophageal varices haemorrhage

Also known as: Esophageal Varices Bleeding / Bleeding Esophageal Varices / Esophageal varices with bleeding / Esophageal varices / Oesophageal varices ruptured / Esophageal varices ruptured / Oesophageal varices with bleeding / Bleeding oesophageal varices / Esophageal varices hemorrhage / Bleeding esophageal varices (disorder)

Drug	Drug Name	Drug Description
DB09099	Somatostatin	A natural peptide hormone used to treat acute bleeding from esophageal varices, gastrointestinal ulcers, and gastritis; prevent pancreatic complications after surgery; and restrict secretions of the upper intestine, pancreas, and biliary tract.
DB02638	Terlipressin	A drug used to treat bleeding caused by esophageal varices.

Drug	Drug Name	Target	Type
DB09099	Somatostatin	Somatostatin receptor type 1	target
DB09099	Somatostatin	Somatostatin receptor type 2	target
DB09099	Somatostatin	Somatostatin receptor type 3	target
DB09099	Somatostatin	Somatostatin receptor type 4	target
DB09099	Somatostatin	Somatostatin receptor type 5	target
DB09099	Somatostatin	P-glycoprotein 1	transporter
DB09099	Somatostatin	Cytochrome P450 3A4	enzyme
DB02638	Terlipressin	Vasopressin V1a receptor	target
DB02638	Terlipressin	Vasopressin V2 receptor	target
DB02638	Terlipressin	Vasopressin V1b receptor	target

Drug	Drug Name	Phase	Status	Count
DB12358	Enbucrilate	3	Unknown Status	1
DB06689	Ethanolamine oleate	3	Unknown Status	1
DB00571	Propranolol	3	Unknown Status	1
DB00641	Simvastatin	3	Completed	1
DB00682	Warfarin	3	Unknown Status	1
DB00104	Octreotide	4	Recruiting	1
DB00571	Propranolol	4	Recruiting	1